Jlb & Associates Inc Novo Nordisk A S Transaction History

Jlb & Associates Inc

  • $725 Million
  • Q3 2024

A detailed history of Jlb & Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Jlb & Associates Inc holds 213,149 shares of NVO stock, worth $18.1 Million. This represents 3.5% of its overall portfolio holdings.

Number of Shares
213,149
Previous 220,483 3.33%
Holding current value
$18.1 Million
Previous $31.5 Million 19.36%
% of portfolio
3.5%
Previous 4.54%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024
SELL
$119.07 - $145.42 $873,259 - $1.07 Million
-7,334 Reduced 3.33%
213,149 $25.4 Million
Q2 2024

Jul 18, 2024
SELL
$122.71 - $146.91 $1.06 Million - $1.27 Million
-8,677 Reduced 3.79%
220,483 $31.5 Million
Q1 2024

Apr 30, 2024
SELL
$102.11 - $135.92 $2.25 Million - $3 Million
-22,079 Reduced 8.79%
229,160 $29.4 Million
Q4 2023

Jan 22, 2024
SELL
$87.78 - $105.45 $1.65 Million - $1.98 Million
-18,791 Reduced 6.96%
251,239 $26 Million
Q3 2023

Nov 01, 2023
BUY
$90.94 - $199.54 $11.7 Million - $25.7 Million
128,916 Added 91.36%
270,030 $24.6 Million
Q2 2023

Jul 20, 2023
SELL
$155.98 - $172.65 $941,339 - $1.04 Million
-6,035 Reduced 4.1%
141,114 $22.8 Million
Q1 2023

Apr 25, 2023
SELL
$132.34 - $159.14 $302,529 - $363,794
-2,286 Reduced 1.53%
147,149 $23.4 Million
Q4 2022

Jan 26, 2023
SELL
$102.55 - $135.33 $451,117 - $595,316
-4,399 Reduced 2.86%
149,435 $20.2 Million
Q3 2022

Oct 19, 2022
SELL
$95.28 - $116.93 $110,143 - $135,171
-1,156 Reduced 0.75%
153,834 $15.3 Million
Q2 2022

Jul 19, 2022
SELL
$103.24 - $121.81 $260,164 - $306,961
-2,520 Reduced 1.6%
154,990 $17.3 Million
Q1 2022

Apr 08, 2022
BUY
$93.1 - $112.54 $1,768 - $2,138
19 Added 0.01%
157,510 $17.5 Million
Q4 2021

Jan 26, 2022
SELL
$95.88 - $117.08 $75,936 - $92,727
-792 Reduced 0.5%
157,491 $17.6 Million
Q3 2021

Nov 10, 2021
SELL
$84.42 - $106.62 $444,133 - $560,927
-5,261 Reduced 3.22%
158,283 $15.2 Million
Q2 2021

Jul 29, 2021
BUY
$67.66 - $84.76 $445,135 - $557,636
6,579 Added 4.19%
163,544 $13.7 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $90,866 - $102,736
1,355 Added 0.87%
156,965 $10.6 Million
Q4 2020

Jan 28, 2021
BUY
$63.89 - $73.8 $82,290 - $95,054
1,288 Added 0.83%
155,610 $10.9 Million
Q3 2020

Oct 16, 2020
BUY
$63.69 - $70.22 $100,502 - $110,807
1,578 Added 1.03%
154,322 $10.7 Million
Q2 2020

Jul 13, 2020
SELL
$58.54 - $67.94 $107,128 - $124,330
-1,830 Reduced 1.18%
152,744 $10 Million
Q1 2020

May 19, 2020
SELL
$49.46 - $64.78 $318,720 - $417,442
-6,444 Reduced 4.0%
154,574 $9.31 Million
Q4 2019

Feb 10, 2020
SELL
$49.86 - $58.26 $106,700 - $124,676
-2,140 Reduced 1.31%
161,018 $9.32 Million
Q3 2019

Oct 29, 2019
BUY
$47.54 - $53.43 $213,359 - $239,793
4,488 Added 2.83%
163,158 $8.44 Million
Q2 2019

Aug 05, 2019
BUY
$46.79 - $52.47 $63,634 - $71,359
1,360 Added 0.86%
158,670 $8.1 Million
Q1 2019

Apr 30, 2019
BUY
$46.36 - $52.63 $10,245 - $11,631
221 Added 0.14%
157,310 $8.23 Million
Q4 2018

Jan 11, 2019
SELL
$41.54 - $47.25 $307,728 - $350,028
-7,408 Reduced 4.5%
157,089 $7.24 Million
Q3 2018

Oct 10, 2018
BUY
$46.76 - $51.24 $68,830 - $75,425
1,472 Added 0.9%
164,497 $7.75 Million
Q2 2018

Jul 09, 2018
BUY
$44.29 - $50.42 $788,583 - $897,728
17,805 Added 12.26%
163,025 $7.52 Million
Q1 2018

Apr 23, 2018
BUY
$48.49 - $58.14 $729,677 - $874,890
15,048 Added 11.56%
145,220 $7.15 Million
Q4 2017

Jan 24, 2018
BUY
$47.53 - $53.73 $812,097 - $918,030
17,086 Added 15.11%
130,172 $6.99 Million
Q3 2017

Oct 12, 2017
BUY
$41.15 - $49.22 $4.65 Million - $5.57 Million
113,086
113,086 $5.45 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jlb & Associates Inc Portfolio

Follow Jlb & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jlb & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jlb & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email